
|Articles|December 9, 2022
Inside Bioprocessing: Microbial bioproduction
Author(s)Thermo Fisher Scientific
The animal origin-free (AOF) trend in bioprocessing has taken a while to reach microbial bioproduction. In this podcast, we explore the reasons behind this and delve into how AOF products are impacting the future of biopharmaceutical manufacturing. We also discuss the first chemically defined microbial medium—the Gibco™ Bacto™ CD Supreme Fermentation Production Medium (FPM). Hydrolysate-free and AOF, this dry powder medium was specially designed to support high-cell-density cultures of E. Coli. Listen to bioprocessing experts and discover more.
Trending on Pharmaceutical Technology
1
Ask the Expert: Complying with Standards
2
How Do CDMOs Scale High-Concentration Biologic Formulations?
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
What Does Overton's FDA Nomination Mean for Drug Reviews?
5